Management of children with acute post-viral cough: a primary care experience with levodropropizine.

IF 1 Q3 PEDIATRICS Minerva Pediatrics Pub Date : 2024-10-31 DOI:10.23736/S2724-5276.24.07691-2

Gian L Marseglia, Daniele Veraldi, Giorgio Ciprandi

{"title":"Management of children with acute post-viral cough: a primary care experience with levodropropizine.","authors":"Gian L Marseglia, Daniele Veraldi, Giorgio Ciprandi","doi":"10.23736/S2724-5276.24.07691-2","DOIUrl":null,"url":null,"abstract":"Background: Acute post-viral cough (APVC) is a disturbing complaint that may also affect the quality of life. As a result, APVC requires an adequate managing with antitussive medications. In this regard, levodropropizine is an effective and safe peripheral antitussive drug.Methods: The present retrospective observational study collected data from children with APVC and treated with levodropropizine for up to seven days. Cough intensity and frequency, impact on children's and parents' sleep, school and games, treatment days, satisfaction, and adverse events were considered.Results: Data from 92 children (mean age 5.5 years) were analyzed globally. Levodropropizine reduced cough intensity and frequency in most children and improved school and game activities and sleep quality in children and their parents. The treatment was safe. Most parents were highly satisfied with the results.Conclusions: This experience showed that levodropropizine was an effective and safe remedy for children with acute post-viral cough.","PeriodicalId":56337,"journal":{"name":"Minerva Pediatrics","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Pediatrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S2724-5276.24.07691-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Acute post-viral cough (APVC) is a disturbing complaint that may also affect the quality of life. As a result, APVC requires an adequate managing with antitussive medications. In this regard, levodropropizine is an effective and safe peripheral antitussive drug.

Methods: The present retrospective observational study collected data from children with APVC and treated with levodropropizine for up to seven days. Cough intensity and frequency, impact on children's and parents' sleep, school and games, treatment days, satisfaction, and adverse events were considered.

Results: Data from 92 children (mean age 5.5 years) were analyzed globally. Levodropropizine reduced cough intensity and frequency in most children and improved school and game activities and sleep quality in children and their parents. The treatment was safe. Most parents were highly satisfied with the results.

Conclusions: This experience showed that levodropropizine was an effective and safe remedy for children with acute post-viral cough.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

病毒感染后急性咳嗽患儿的治疗：左旋多巴的基层医疗经验。

背景：病毒感染后急性咳嗽（APVC）是一种令人不安的主诉，也可能影响生活质量。因此，急性病毒后咳嗽需要适当的止咳药物治疗。在这方面，左旋多巴是一种有效、安全的外周止咳药：本回顾性观察研究收集了患有 APVC 并接受左旋多巴治疗长达七天的儿童的数据。研究考虑了咳嗽强度和频率、对儿童和家长睡眠、学习和游戏的影响、治疗天数、满意度和不良反应等因素：对 92 名儿童（平均年龄 5.5 岁）的数据进行了全面分析。左旋多巴嗪降低了大多数儿童的咳嗽强度和频率，改善了儿童及其父母的学校和游戏活动以及睡眠质量。治疗是安全的。大多数家长对治疗效果非常满意：这一经验表明，左旋多巴嗪是治疗病毒感染后急性咳嗽患儿的一种有效而安全的药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Minerva Pediatrics

CiteScore

2.50

自引率

0.00%

发文量

294